1. AB0248 Clinical Significance of Soluble Vascular Endothelial-Cadherin and Anti-Vascular Endothelial-Cadherin Antibody in Rheumatoid Arthritis Treated with Etanercept or Adalimumab. (9th June 2015) Authors: Banse, C.; Polena, H.; Stidder, B.; Khallil-Mgharbel, A.; Houivet, E.; Lequerré, T.; Fardellone, P.; Le Loet, X.; Philippe, P.; Marcelli, C.; Vilgrain, I.; Vittecoq, O. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0484 Impact of TNF Antagonists on the Joint Manifestations of Sarcoidosis. (23rd January 2014) Authors: Banse, C.; Bisson-Vaivre, A.; Kozyreff-Meurice, M.; Dominique, S.; Vittecoq, O.; Goeb, V. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A328 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗